Esposito Marco, Maghaireh Hassan, Grusovin Maria Gabriella, Ziounas Ioannis, Worthington Helen V
Cochrane Oral Health Group, School of Dentistry, The University of Manchester, Manchester, UK.
Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD006697. doi: 10.1002/14651858.CD006697.pub2.
Dental implants are usually placed by elevating a soft tissue flap, but in some instances, they can also be placed flapless reducing patient discomfort. Several flap designs and suturing techniques have been proposed. Soft tissues are often manipulated and augmented for aesthetic reasons. It is often recommended that implants are surrounded by a sufficient width of attached/keratinised mucosa to improve their long-term prognosis.
To evaluate whether (1a) flapless procedures are beneficial for patients, and (1b) which is the ideal flap design; whether (2a) soft tissue correction/augmentation techniques are beneficial for patients, and (2b) which are the best techniques; whether (3a) techniques to increase the peri-implant keratinised mucosa are beneficial for patients, and (3b) which are the best techniques; and (4) which are the best suturing techniques/materials.
The following electronic databases were searched: the Cochrane Oral Health Group Trials Register (to 9 June 2011), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 2), MEDLINE via OVID (1950 to 9 June 2011), EMBASE via OVID (1980 to 9 June 2011). Several dental journals were handsearched. There were no language restrictions.
All randomised controlled trials (RCTs) of root-form osseointegrated dental implants, with a follow-up of at least 6 months after function, comparing various techniques to handle soft tissues in relation to dental implants. Outcome measures, according to the different hypotheses, were: prosthetic and implant failures, biological complications, aesthetics evaluated by patients and dentists, postoperative pain, marginal peri-implant bone level changes on periapical radiographs, patient preference, ease of maintenance by patient, soft tissue thickness changes and attached/keratinised mucosa height changes.
Screening of eligible studies, assessment of the methodological quality of the trials and data extraction were conducted at least in duplicate and independently by two or more review authors. Trial authors were contacted for missing information. Results were expressed using risk ratios for dichotomous outcomes and mean differences for continuous outcomes with 95% confidence intervals.
Seventeen potentially eligible RCTs were identified but only six trials with 138 patients in total could be included. One study was at low risk of bias, two studies were judged to be at unclear risk of bias and three at high risk of bias. Two trials (56 patients) compared flapless placement of dental implants with conventional flap elevation, one trial (10 patients) compared crestal versus vestibular incisions, one trial (20 patients) Erbium:YAG laser versus flap elevation at the second-stage surgery for implant exposure, one split-mouth trial (10 patients) evaluated whether connective tissue graft at implant placement could be effective in augmenting peri-implant tissues, and one trial (40 patients) compared autograft with an animal-derived collagen matrix to increase the height of the keratinised mucosa. On a patient, rather than per implant basis, implants placed with a flapless technique and implant exposures performed with laser induced statistically significantly less postoperative pain than flap elevation. Sites augmented with soft tissues connective grafts showed a better aesthetic and thicker tissues. Both palatal autografts or the use of a porcine-derived collagen matrix are effective in increasing the height of keratinised mucosa at the price of a 0.5 mm recession of peri-implant soft tissues. There were no other statistically significant differences for any of the remaining analyses.
AUTHORS' CONCLUSIONS: There is limited weak evidence suggesting that flapless implant placement is feasible and has been shown to reduce patient postoperative discomfort in adequately selected patients, that augmentation at implant sites with soft tissue grafts is effective in increasing soft tissue thickness improving aesthetics and that one technique to increase the height of keratinised mucosa using autografts or an animal-derived collagen matrix was able to achieve its goal but at the price of a worsened aesthetic outcome (0.5 mm of recession). There is insufficient reliable evidence to provide recommendations on which is the ideal flap design, the best soft tissue augmentation technique, whether techniques to increase the width of keratinised/attached mucosa are beneficial to patients or not, and which are the best incision/suture techniques/materials. Properly designed and conducted RCTs, with at least 6 months of follow-up, are needed to provide reliable answers to these questions.
牙种植体通常通过掀起软组织瓣来植入,但在某些情况下,也可采用不翻瓣植入,以减轻患者不适。目前已提出了多种瓣设计和缝合技术。出于美学原因,软组织常需进行处理和增量。通常建议种植体周围有足够宽度的附着/角化黏膜,以改善其长期预后。
评估(1a)不翻瓣手术对患者是否有益,以及(1b)理想的瓣设计是什么;(2a)软组织矫正/增量技术对患者是否有益,以及(2b)最佳技术有哪些;(3a)增加种植体周围角化黏膜的技术对患者是否有益,以及(3b)最佳技术有哪些;以及(4)最佳的缝合技术/材料是什么。
检索了以下电子数据库:Cochrane口腔健康组试验注册库(截至2011年6月9日)、Cochrane对照试验中央注册库(CENTRAL)(《Cochrane图书馆》2011年第2期)、通过OVID检索的MEDLINE(1950年至2011年6月9日)、通过OVID检索的EMBASE(1980年至2011年6月9日)。还手工检索了几本牙科杂志。无语言限制。
所有关于根形骨结合牙种植体的随机对照试验(RCT),在功能后至少随访6个月,比较与牙种植体相关的各种软组织处理技术。根据不同假设,结局指标包括:修复和种植体失败、生物学并发症、患者和牙医评估的美学效果、术后疼痛、根尖片上种植体周围边缘骨水平变化、患者偏好、患者维护的难易程度、软组织厚度变化以及附着/角化黏膜高度变化。
由两名或更多综述作者至少重复且独立地进行合格研究的筛选、试验方法学质量评估和数据提取。与试验作者联系获取缺失信息。结果以二分类结局的风险比和连续结局的均值差异表示,并给出95%置信区间。
共识别出17项潜在合格的RCT,但仅纳入了6项试验,共138例患者。1项研究偏倚风险低,2项研究偏倚风险不明确,3项研究偏倚风险高。两项试验(56例患者)比较了牙种植体的不翻瓣植入与传统翻瓣,一项试验(10例患者)比较了嵴顶切口与前庭切口,一项试验(20例患者)比较了铒激光与二期手术翻瓣暴露种植体,一项半口试验(10例患者)评估了种植时结缔组织移植对增加种植体周围组织是否有效,一项试验(40例患者)比较了自体骨移植与动物源性胶原基质以增加角化黏膜高度。在患者层面而非每个种植体层面,采用不翻瓣技术植入的种植体和激光诱导暴露的种植体术后疼痛在统计学上显著低于翻瓣。用软组织结缔组织移植增量的部位显示出更好的美学效果和更厚的组织。腭部自体骨移植或使用猪源性胶原基质均能有效增加角化黏膜高度,但代价是种植体周围软组织退缩0.5mm。其余任何分析均未发现其他统计学显著差异。
有有限的薄弱证据表明,不翻瓣种植植入是可行的,且已证明在适当选择的患者中可减轻患者术后不适;种植部位用软组织移植增量可有效增加软组织厚度,改善美学效果;一种使用自体骨移植或动物源性胶原基质增加角化黏膜高度的技术能够实现其目标,但代价是美学效果变差(退缩0.5mm)。没有足够可靠的证据就理想的瓣设计、最佳的软组织增量技术、增加角化/附着黏膜宽度的技术对患者是否有益以及最佳的切口/缝合技术/材料等提供建议。需要进行设计合理且实施得当、至少随访6个月的RCT,以可靠回答这些问题。